Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Frontiers in Cardiovascular Medicine|September 8, 2022
Isoprenaline modified the lipidomic profile and reduced β-oxidation in HL-1 cardiomyocytes: In vitro model of takotsubo syndromeIvana Fiserova, Minh Duc Trinh, Moustafa Elkalaf, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 18, 2019
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION studySalvatore Brugaletta, Tommaso Gori, Petr Tousek, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction)Salvatore Brugaletta, Tommaso Gori, Adrian F Low, et al.
American Heart Journal|December 17, 2016
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)Pavel Osmancik, Petr Tousek, Dalibor Herman, et al.
Journal of the American College of Cardiology|November 8, 2021
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerationsJ Wouter Jukema, Maddalena Lettino, Petr Widimský, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registriesUwe Zeymer, Petr Widimsky, Nicolas Danchin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registriesNicolas Danchin, Maddalena Lettino, Uwe Zeymer, et al.
Pageof 6